Considering that eliminating the IL-13-producing cells or neutralizing IL-13 is reported to improve salivary gland function in a mouse model of Sjögren syndrome,33 targeting IL-13 might be a promising therapeutic strategy for treatment of IgG4-RS through modulating the progression of cellular senescence. The gene discussed is IL13; the disease is Sjogren syndrome.